Introduction
The EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have been in force for years now, but "in force" and "fully enforced" are two different things, and the gap between them is where a lot of current medical device regulatory affairs hiring activity is concentrated. Extended transition periods, phased certification deadlines, and an ongoing notified body capacity crunch mean that the practical impact of these regulations on company operations, and on what regulatory affairs skills employers are actively recruiting for, is still very much unfolding rather than settled. This article looks at what is actually driving hiring demand in this space and what it means for regulatory professionals working in or targeting the European medical device market.
A Quick Refresher on MDR and IVDR
MDR and IVDR replaced the EU's older device directives with a substantially more demanding framework: more rigorous clinical evidence requirements, expanded post-market surveillance and vigilance obligations, a more structured technical documentation format, and new requirements around unique device identification and traceability. IVDR in particular represented a major shift for in vitro diagnostic manufacturers, moving most IVD products into higher-scrutiny conformity assessment routes that previously did not require notified body involvement at all. Both regulations also introduced a formal role, the Person Responsible for Regulatory Compliance, that companies must designate and that did not exist in the same form under the earlier directives.
Why Enforcement Timing Matters More Than the Regulations Themselves
The text of MDR and IVDR has been largely settled for a while. What keeps shifting, and what keeps generating hiring activity, is the practical enforcement timeline: extended transition deadlines for certain device classes, phased-in requirements for legacy devices still certified under the old directives, and evolving guidance from the Medical Device Coordination Group on how specific requirements should be interpreted. Each extension or clarification tends to trigger a fresh wave of internal project work, reassessing a company's compliance timeline, updating technical documentation to reflect new guidance, or re-scoping a certification strategy, and that project work is frequently where new regulatory affairs roles get created or existing ones get reprioritized.
The Notified Body Bottleneck and What It Means for Hiring
A persistent constraint under MDR and IVDR has been limited notified body capacity relative to the volume of certifications required, which has made certification timelines less predictable for many manufacturers. This has a direct hiring consequence: companies increasingly value regulatory affairs professionals who can build a submission package that is genuinely complete and well-organized on first submission, because a submission that generates a lengthy round of notified body questions costs a company real time in a system where re-queuing for review capacity is itself a scarce resource. Experience specifically with notified body interactions under MDR or IVDR, not just familiarity with the regulation's text, has become a distinct and valued credential in its own right.
New Demand: Clinical Evaluation and Post-Market Surveillance Expertise
MDR's more demanding clinical evidence requirements have measurably increased demand for regulatory professionals who can write and defend a clinical evaluation report, and for those who understand how to structure an ongoing post-market clinical follow-up plan rather than treating clinical evidence as a one-time submission exercise. Similarly, MDR and IVDR's expanded post-market surveillance and vigilance obligations have created ongoing roles, not just project-based ones, focused on monitoring real-world device performance, managing periodic safety update reports, and maintaining the systematic post-market surveillance plan every manufacturer is now required to keep current. Companies that treated post-market surveillance as a lighter-touch, largely reactive function under the old directives have generally had to build out dedicated capacity for it under the new framework.
Where the Jobs Are Concentrated
Hiring activity tied to MDR and IVDR compliance work is not evenly distributed. It tends to concentrate in a few places: companies with large legacy device portfolios that still need re-certification under the new framework, in vitro diagnostic manufacturers who face a larger relative jump in requirements than most device manufacturers, and mid-sized companies that previously relied on a smaller regulatory function and have had to scale it up meaningfully to keep pace with the new documentation and surveillance burden. Consulting firms and regulatory service providers that support smaller manufacturers through certification and re-certification have also expanded specifically to meet demand from companies that cannot justify building this expertise fully in-house.
Smaller manufacturers deserve particular attention here, because they have often been affected disproportionately. A large company can typically absorb the cost of scaling up a regulatory function to meet MDR or IVDR's documentation and surveillance burden, while a small or early-stage device company facing the same requirements may have only one or two regulatory staff to begin with. That imbalance has pushed a meaningful amount of hiring toward regulatory consultancies and contract regulatory professionals who can support several smaller manufacturers at once, which is itself a distinct and growing career path for professionals with strong MDR or IVDR experience who are comfortable working across multiple clients rather than a single employer.
Skills That Are Newly Valuable
A few specific capabilities have become more clearly differentiating in this hiring environment: direct experience navigating a notified body review under the current framework rather than the older directives; the ability to write clinical evaluation reports and post-market clinical follow-up plans that hold up to scrutiny; familiarity with the technical documentation structure MDR and IVDR require, which differs meaningfully from the older directive format; and comfort managing an ongoing, systematic post-market surveillance program rather than a lighter periodic review process. Regulatory professionals who can speak concretely to hands-on experience in these areas, rather than general familiarity with the regulation's requirements, tend to stand out in this market.
Cross-border regulatory strategy experience has also become more valuable than it was under the older directive framework. Because notified body capacity and interpretive practice can vary somewhat between designated bodies, and because IVDR in particular reclassified a large share of diagnostic products into categories requiring notified body involvement for the first time, companies increasingly want regulatory staff who understand how to sequence a certification strategy across multiple device classes and, where relevant, multiple notified bodies, rather than staff who have only ever worked one certification pathway from start to finish.
What This Means If You're Job Searching in Medical Device Regulatory Affairs
If you are targeting roles in the European medical device or diagnostics market, it is worth being specific in how you describe your MDR or IVDR experience rather than listing the regulations generically on a resume. Naming the actual work, preparing a technical documentation package for a specific device class, managing a notified body review to completion, building or maintaining a post-market surveillance system, gives a hiring manager something concrete to evaluate, and it signals the kind of hands-on experience that this hiring environment currently rewards most. If you do not yet have that experience, volunteering for MDR or IVDR-related project work at your current employer, even in a supporting capacity, is one of the more direct ways to build a credential that is currently in real demand.
The Person Responsible for Regulatory Compliance and What It Signals About Hiring
MDR and IVDR both require manufacturers to designate at least one Person Responsible for Regulatory Compliance, an individual who must meet specific qualification criteria around education and professional experience and who holds defined responsibilities for conformity, technical documentation, post-market surveillance, and vigilance reporting. The existence of this formally defined role has had a hiring effect beyond the individuals who actually hold the title: it has made companies think more explicitly about who on their regulatory team could plausibly meet the role's qualification bar, and it has pushed some companies to hire more senior regulatory professionals earlier than they otherwise might have, specifically to ensure they have someone qualified in place well before a certification deadline arrives. For regulatory professionals building toward more senior roles, understanding the specific qualification criteria for this position, and being able to speak to how your experience maps onto them, is worth doing even if you are not yet the one holding the designation.
Legacy Device Transition Work as a Distinct Hiring Driver
A significant share of current MDR and IVDR-related hiring is not tied to new product launches at all, but to the transition of previously certified legacy devices onto the new framework before extended deadlines expire. This work has a different character than new-product regulatory strategy: it is heavily document-and-gap-analysis driven, comparing existing technical documentation against MDR or IVDR's more demanding requirements, identifying what additional clinical or performance data is needed to close the gap, and sequencing a large portfolio of devices through re-certification within a fixed and often tight timeline. Companies with large legacy portfolios frequently hire specifically for this transition work, sometimes on a contract or fixed-term basis tied to the certification deadline itself, which means candidates comfortable with structured, deadline-driven documentation work, not just regulatory strategy, are in real demand for this specific kind of role.
Conclusion
MDR and IVDR are not new regulations anymore, but their enforcement is still an active, evolving process, and that ongoing evolution, not the original rollout, is what is currently driving a meaningful share of medical device regulatory affairs hiring in Europe. The professionals benefiting most from this environment are the ones who can point to concrete, hands-on experience with notified body reviews, clinical evaluation, and post-market surveillance under the current framework, rather than general familiarity with what the regulations say.